Live tape
Top 8, mentions 7d30,017NVDA14,564 mentions▲ +0.04ANT4,160 mentions▲ +0.06GOOGL2,936 mentions▲ +0.04SPY2,248 mentions▲ +0.05QQQ1,804 mentions▲ +0.04SPCX1,748 mentions▲ +0.08AMD1,367 mentions▲ +0.06AAPL1,190 mentions▲ +0.04

Equity · Healthcare

GMAB

NASDAQ

Genmab A/s (GMAB)

50.62 USD −1.38% vs prior close Nov 20, 2026
Genmab A/S price graph
20 sessions
60 40 26 Oct 20 Nov

The line runs 45.20 USD on 26 October through 50.62 USD on 20 November, on a scale from 40 to 60. Days the market did not trade hold the previous close, flat.

Revenue, year to Dec 2025
3.7B USD
EPS, diluted, year to Dec 2025
15.37 USD
52-week range
23.85 USD – 57.34 USD
Avg volume
590.9K
Mentions, 30 days
1

as of Nov 20, 2026

Which funds hold Genmab A/s (GMAB)?

8 of the 45 institutional funds we track reported a Genmab A/s position for the quarter ended 30 Sep 2026 — a combined 531.9M USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Genmab A/s (GMAB)?
FundPositionSharesValueShares q/q
Two Sigma InvestmentsAdded5,252,719187.4M USD+49.8%
Point72 Asset ManagementAdded3,535,080126.1M USD+2,506.1%
Renaissance TechnologiesTrimmed2,272,45081.1M USD−35.4%
Citadel AdvisorsTrimmed1,729,32361.7M USD−30.2%
Marshall WaceAdded1,219,99843.5M USD+47.0%
Millennium ManagementHeld (±25%)756,49627.0M USD−16.9%
AQR Capital ManagementAdded133,5824.8M USD+25.9%
Maverick CapitalNew position10,683381K USD

Have members of Congress traded Genmab A/s (GMAB)?

The most recent congressional trade disclosed in Genmab A/s is a purchase by Josh Gottheimer (house, NJ), dated 16 Jan 2025.

STOCK Act disclosures

Have members of Congress traded Genmab A/s (GMAB)?
TradedMemberTypeAmountFiled after
16 Jan 2025Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD25 days
16 Dec 2024Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD29 days
19 Jul 2024Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD27 days
18 Jun 2024Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD21 days
16 Oct 2023Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD26 days
15 Sep 2023Josh Gottheimerhouse · Democrat–NJSale1K USD–15K USD30 days
20 Jul 2023Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD32 days
19 Jul 2023Josh Gottheimerhouse · Democrat–NJPurchase1K USD–15K USD33 days

What has been filed or recorded for Genmab A/s (GMAB)?

The filings we hold for Genmab A/s, newest first: 8 fails-to-deliver days and 5 reported financial figures, the latest dated 30 Oct 2026.

What has been filed or recorded for Genmab A/s (GMAB)?
And
30 Oct 2026Fails to deliverShares failed to deliver150,000 shares8.5M USD notional
29 Oct 2026Fails to deliverShares failed to deliver42,502 shares2.4M USD notional
28 Oct 2026Fails to deliverShares failed to deliver1,940 shares87K USD notional
27 Oct 2026Fails to deliverShares failed to deliver1,194 shares53K USD notional
26 Oct 2026Fails to deliverShares failed to deliver3,412 shares149K USD notional
23 Oct 2026Fails to deliverShares failed to deliver588 shares24K USD notional
15 Oct 2026Fails to deliverShares failed to deliver1,082 shares40K USD notional
08 Oct 2026Fails to deliverShares failed to deliver125 shares5K USD notional
31 Dec 2025FinancialsRevenue3.7B USDfiscal year
31 Dec 2025FinancialsNet income963.0M USDfiscal year
31 Dec 2025FinancialsDiluted earnings loss per share15.37 USDfiscal year
31 Dec 2025FinancialsTotal assets12.9B USDat period end
31 Dec 2025FinancialsEquity5.8B USDat period end

What is Reddit saying about Genmab A/s (GMAB)?

Reddit mentioned GMAB 1 times in the 30 days to 21 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 21 November 2026.

30-day window, Method

1mentions, 30 days
1communities

How do Reddit mentions of Genmab A/s (GMAB) compare with its price?

Share ↗
1 mentions

Before our first record — not zero

Which subreddits are talking about Genmab A/s (GMAB)?

30 days

Which subreddits are talking about Genmab A/s (GMAB)?
CommunityShareMentionsNet sentiment
r/stocks100%1+0.16

What do people ask about Genmab A/s (GMAB)?

From live data
What did Genmab A/s shares close at?50.62

Genmab A/s closed at 50.62 USD on 20 Nov 2026, down 1.38% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Genmab A/s’ revenue?3.7B

Genmab A/s reported revenue of 3.7B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Which funds own Genmab A/s?8 of 45

8 of the 45 funds we track reported a Genmab A/s position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Point72 Asset Management and Renaissance Technologies. See Funds

Have members of Congress traded Genmab A/s?9 trades

Yes. 9 trades in Genmab A/s appear in the congressional disclosures we hold; the latest is a purchase by Josh Gottheimer (House, NJ) dated 16 Jan 2025, filed 10 Feb 2025. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

What is Reddit saying about Genmab A/s?0 mentions

Genmab A/s was mentioned 0 times in the last 7 days across the finance subreddits we track, and 1 times over the trailing 30 days. Of the 1 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGAR13F filings
  5. Wikimedia CommonsPortraits via Wikimedia Commons. Josh Gottheimer: Kristie Boyd; U.S. House Office of Photography, Public domain.
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SECSEC fails-to-deliver (CNS) data
  8. SEC EDGARXBRL company facts, latest period ended 31 Dec 2025
  9. SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words